Objective: During the COVID-19 outbreak, the medical sector services to the public were reportedly not appropriate. Due to the novelty of the disease, the patients were not aware of the right treatment and what health facilities were required. Method: The current research is designed to determine the relationship between prognosis markers and patient health behavior…
FreeMedArt — Free Medical Articles
On FreeMedArt.ru, you can read scientific medical news for free and get an access to medical articles from reputable authors. We are strongly for Open access and Open science Why does it hurt …? How to treat …? What helps …? What to do when …? The answers to these and other questions can be found here.
Category: Prognosis
Clinical manifestations of active tuberculosis patients coinfected with severe acute respiratory syndrome coronavirus-2 by Gul Habib
CONCLUSION: Tuberculosis coinfection augmented the severity of COVID-19 and the likelihood of death, and high vigilance is recommended for respiratory pathogens in COVID-19.
Potential predictive value of CT radiomics features for treatment response in patients with COVID-19 by Gang Huang
CONCLUSION: This new, non-invasive, and low-cost prediction model that combines the radiomics and clinical features is useful for identifying COVID-19 patients who may not respond well to treatment.
COVID-19 in pediatric nephrology centers in Turkey by Emre Leventoğlu
BACKGROUND: There is limited data on COVID-19 disease in children with kidney disease. We aimed to investigate the characteristics and prognosis of COVID-19 in pediatric nephrology patients in Turkey.
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study by Riccardo Nevola
CONCLUSION: This study shows similar effectiveness among mAbs used regardless of vaccination status and identifies COVID-19 patients in whom mAbs have poor activity.
COVID19-associated new-onset movement disorders: a follow-up study by Susanne A Schneider
CONCLUSIONS: The prognosis of new-onset COVID-19-associated movement disorder appears to be generally good. The majority recovered without residual symptoms within several weeks or months. Permanent cases may be due to unmasking of a previous subclinical movement disorder or due to vascular/demyelinating damage. Given the relatively low response rate of one third only and the heterogeneity…
Biomarkers of endothelial dysfunction are associated with poor outcome in COVID-19 patients: A systematic review and meta-analysis by Alireza Mohebbi
Numerous studies have linked coronavirus disease 2019 (COVID-19) with endothelial dysfunction and reported elevated levels of endothelial biomarkers in this disease. We conducted a systematic review and meta-analysis of the published evidence in this respect. A systematic literature search of PubMed and Scopus databases was performed to find studies investigating biomarkers of endothelial dysfunction in…
No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients by Quentin Philippot
SARS-CoV2 infection has a poor prognosis in patients affected of idiopathic pulmonary fibrosis (IPF). Autoantibodies (auto-Abs) neutralizing type I interferons (IFNs) are found in the blood of at least 15% of patients with life-threatening COVID-19 pneumonia. Because of the elevated prevalence of some auto-Abs in IPF patients, we hypothesize that the prevalence of auto-Abs neutralizing…
IL-6 Serum Levels in COVID-19 Patients With Vertigo by Dimitrios Kitsos
Introduction Dizziness and vertigo represent well-established symptoms of COVID-19. An overexpression of cytokines, a condition often described with the term “cytokine storm” or “hypercytokinemia”, is a key characteristic of SARS-Cov-2 infection and plays a pivotal role in disease progression and prognosis. Among them, IL-6 is of major importance. Purpose The purpose of this study is…
B cell-related tertiary lymphoid structure may exert inhibitory effects on lung adenocarcinoma and SARS-COV-2 by Kang Sun
CONCLUSION: TLS1 structure may improve the prognosis of patients with LUAD and SARS-COV-2 (Severe acute respiratory syndrome coronavirus 2). This unexpected discovery provides new insight into the comprehensive treatment of patients with LUAD and SARS-COV-2.
The Post-Venous Thromboembolism Functional Status Scale: From Call to Action to Application in Research, Extension to COVID-19 Patients, and Its Use in Clinical Practice by Cindy M M de Jong
A broad spectrum of long-term sequelae may be present in venous thromboembolism (VTE) survivors, affecting their quality of life and functioning. To monitor recovery and improve the prognosis of patients with persistent functional limitations, the development of a new outcome measure that could better capture the consequences of VTE was an unmet need. Starting as…
Mortality and Severity of Coronavirus Disease 2019 in Patients with Long-Term Glucocorticoid Therapy: A Korean Nationwide Cohort Study by Eu Jeong Ku
BACKGROUND: The severity of coronavirus disease 2019 (COVID-19) among patients with long-term glucocorticoid treatment (LTGT) has not been established. We aimed to evaluate the association between LTGT and COVID-19 prognosis.
English
Arabic
Russian
French
Chinese (Simplified)
Japanese
Portuguese
Spanish